MedWatch·Financial report·Business & finance·2w agoGN plans DKK 4bn in share buybacks after hearing aid saleThe sale of GN's hearing aid division to Amplifon accelerates retail consolidation in the global audiology market, which could affect product availability, pricing, and independent clinic competitive dynamics.
Audiology Worldnews·Financial report·Business & finance·7w agoManufacturers’ H1 financial reports provide clear window on the market’s healthy businessesThe potential GN-Amplifon merger could reshape the competitive landscape of hearing aid distribution and retail across Europe and beyond, with downstream effects on pricing, product access, and independent clinic viability.+Save
MedWatch·Financial report·Business & finance·8w agoGN shares rise as major bank sees potential for significant revaluationGN's financial trajectory affects its capacity to invest in hearing care R&D and its competitive position in the broader audiology market.+Save
MedWatch·Financial report·Business & finance·2mo agoBanks say GN's Amplifon stake is likely to yield unexpected profitsA potential billion-dollar investment gain for GN could strengthen its balance sheet, influencing future R&D spending, acquisitions, and competitive positioning across the global hearing care market.+Save
MedWatch·Industry news·Business & finance·2mo agoHearing aid manufacturer falls behind in the growth race: A sign of fierce competitionShifts in competitive balance among the top hearing aid makers can influence product availability, pricing, and technology investment, which ultimately shapes the devices audiologists can offer patients.+Save
MedWatch·Industry news·Hearing aids·2mo agoAfter three-year wait, new platform aims to put WSA back on topWS Audiology's platform refresh after a three-year gap is a significant competitive development that could shift market-share dynamics among the top-five hearing aid manufacturers.+Save
MedWatch·Industry news·Business & finance·3mo agoGN delays online business profit target againRepeated delays in profitability for GN's direct-to-consumer online channel signal ongoing challenges in the OTC and e-commerce hearing aid market, which could influence how the sector invests in online sales models.+Save
Aurahear·Product announcement·Hearing aids·3mo agoGN launches ReSound Sensia with the aim of lifting conversationsThe ReSound Sensia represents GN's latest push to integrate AI-driven speech processing and next-generation Bluetooth (Auracast) connectivity into a single platform, signalling a broader industry trend toward public-venue streaming compatibility.+Save
MedWatch·Industry news·Business & finance·4mo agoMedia: Investors criticize GN board following hearing aid business saleThe exclusion of top-tier bidders from GN's hearing aid sale could reshape ownership and competition in the global hearing aid market, with downstream effects on product availability and pricing for clinics and patients.+Save
Hearing Tracker·Industry news·Business & finance·5mo agoGN CEO Peter Karlströmer on GN-Amplifon Deal: “We’re Creating an Even Stronger Company”A deeper alliance between a major hearing aid manufacturer (GN) and the world's largest retail hearing care network (Amplifon) could concentrate market power and influence distribution, pricing, and brand access for independent audiologists and clinics.+Save
MedWatch·Financial report·Business & finance·6mo agoDanske Bank sees potential focus on Demant’s miniature product launch and GN’s sale to Amplifon in interim reportA potential GN–Amplifon deal and Demant's product pipeline are market-shaping events that could alter competitive dynamics, pricing, and product availability across audiology clinics globally.+Save